Synthetic Biologics, Inc.
BETA-LACTAMASES WITH IMPROVED PROPERTIES FOR THERAPY

Last updated:

Abstract:

This invention relates to, in part, compositions of beta-lactamases and methods of using these enzymes in, for example, gastrointestinal tract (GI tract) disorders such as C. difficile infection (CDI).

Status:
Application
Type:

Utility

Filling date:

8 Dec 2021

Issue date:

31 Mar 2022